Group-specific distal enhancers or SEs could control TSGs such as DLC1 and MAPK10 directly or indirectly via group-specific core regulators, which might help to explain the downregulation of these TSGs and tumor progression in GII (Fig. 5a). Here, DLC1 is linked to neoplasm.